PEP-35

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePEP-35
Drug Alias NameHyaluronic acid binding peptide (Cangene)PEP-35
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHyaluronic acid modulators
TargetsHyaluronic acid
Therapy Area/IndicationsStaphylococcal InfectionsPseudomonas InfectionsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCangene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCangene Corp
Active IndicationsN/A
Inactive IndicationsStaphylococcal InfectionsPseudomonas InfectionsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A